HOXA-AS3 and non-small cell lung carcinoma: To determine the role of HOXA-AS3 in mediating resistance to chemotherapy, four NSCLC cell lines (A549, PC-9, NCI-H358, and NCI-H1299) were used to investigate the effect of cisplatin treatment.